ImmunoGen vs Pyxis Oncology
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need
34 employees · est. 1981
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer
68 employees · est. 2019 · Boston, United States
ImmunoGen is the older company (1981 vs 2019); Pyxis Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | ImmunoGen | Pyxis Oncology |
|---|---|---|
| Founded | ||
| Founded | 1981 older | 2019 |
| Headquarters | ||
| Headquarters | Not tracked yet | Boston, United States |
| Employees | ||
| Employees | 34 | 68 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Not tracked yet |
| Total Funding | ||
| Total Funding | $681.30M | $392.00M |
| Funding Rounds | ||
| Funding Rounds | 11 | 4 |
| Services | ||
| Services | Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support | development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers, Research Institutions | patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers |
| Taxonomy | ||
| Taxonomy | Antibody-drug ConjugatesCancer TreatmentOncologyImmunologyNeuroscienceTherapeutics Development +6 | Antibody-Drug ConjugatesImmunotherapyCancer TreatmentBiologicsTumor TargetingImmune Suppression Overcoming +8 |
| Website | ||
| Website | immunogen.com | pyxisoncology.com |
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while spari...
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...
Also comparing in this category
Comparing more than these two?
Get ImmunoGen, Pyxis Oncology and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ImmunoGen compare?
A PDF of ImmunoGen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare ImmunoGen with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ImmunoGen on 10 Jun 2026, and Pyxis Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
